[Gujarat, India April 23, 2025] — Premier Medical Corporation is pleased to announce the launch of the First Response® Malaria Ag. P. falciparum (HRP2/pLDH) Combo Card Test, a next-generation rapid diagnostic solution designed to support fast and reliable malaria detection in both laboratory and point-of-care settings.

Engineered for use by trained healthcare professionals, the test delivers qualitative screening for two key malaria antigens—Histidine Rich Protein 2 (HRP2) and Plasmodium lactate dehydrogenase (pLDH)—enabling accurate identification of Plasmodium falciparum infections.

This advanced combo test offers 100% sensitivity and 100% specificity, ensuring dependable results. With a rapid turnaround time of 20–30 minutes, it supports timely diagnosis and intervention, especially in high-burden regions.

Key Product Features

• 100% Sensitivity and 100% Specificity

• Rapid results: 20–30 minutes

• Dual-antigen detection: HRP2 and pLDH

• Suitable for laboratory and point-of-care testing environments

• Whole blood specimen

• Stable storage at 1°C – 40°C

• Easy-to-use, card-based test format

Premier Medical Corporation remains committed to providing high-quality diagnostic solutions that enhance early detection and improve patient outcomes worldwide.

For more information about the First Response® Malaria Ag. P. falciparum (HRP2/pLDH) Combo Card Test, contact our customer support team or visit our product pages.